SKI Market

Indian Indices

Sensex

85,188.60 -32.00
( -0.04%)

Global Indices

Nasdaq

48,084.29 -303.78
(-0.63%)

Dow Jones

6,866.50 -50.74
(-0.73%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

41.37

817.04

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.22

Back

Remedium Lifecare standalone net profit declines 96.07% in the September 2025 quarter

Nov 24,2025

Net profit of Remedium Lifecare declined 96.07% to Rs 0.07 crore in the quarter ended September 2025 as against Rs 1.78 crore during the previous quarter ended September 2024. Sales declined 65.79% to Rs 8.58 crore in the quarter ended September 2025 as against Rs 25.08 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8.58	25.08	-66
OPM %	-34.85	17.78	-
PBDT	0.07	2.47	-97
PBT	0.07	2.46	-97
NP	0.07	1.78	-96

85,188.60 -32.00 ( -0.04%)

48,084.29 -303.78 (-0.63%)

6,866.50 -50.74 (-0.73%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)